NEW YORK (GenomeWeb News) – The US Department of Defense has given CombiMatrix a $250,000 grant to conduct a proof-of-concept program to find new uses for the company’s microarray technology, the company said today.
The funding from the Defense Advanced Research Projects Agency (DARPA) is focused on using its ElectraSense reader and its array technology to “explore largely uncharted capabilities and applications that are inherent in our core technologies," CombiMatrix’s Homeland Security and Defense Programs Director David Danley said in a statement.
The goal is to develop molecular synthesis technology with CombiMatrix’s electrochemical detection techniques to create label-free detection systems for use in diagnostics, chemical measurement, and chemical agent detection, the company said.
"While there are specific military needs and goals associated with this contract, the success of this program will enable commercial non-military applications and products addressing markets such as diagnostics, chemical sensing, analytics, and others,” CombiMatrix CEO Amit Kumar said in a statement.
Kumar also said the company hopes that if this program is successful it will lead to additional grants and contracts from DOD.